CD8A and neoplasm: Not in strict sense an standard IC, OVA linked to an antibody specific for a C‐type lectin receptor DNGR‐1 found on CD8+ conventional DCs elicited strong CD8+ T‐cell activation and eliminated OVA‐positive B16 tumor in vivo (Sancho et al, 2008).